Cyber Monday spending to hit $11.6 bln – report Crypto shares fall on BlockFi bankruptcy filing Biogen down after death in Alzheimer drug trial Indexes end: S&P 500 -1.54%, Nasdaq -1.58%, Dow -1.45% Nov 28 (Reuters) – US stocks ended sharply lower on Monday after protests in major Chinese cities against strict COVID-19 policies sparked … Read more
Take-Two, Lyft slump on downbeat forecasts Amgen climbs on cholesterol drug data Indexes: S&P 500 +0.56%, Nasdaq +0.49%, Dow +1.02% Nov 8 (Reuters) – Wall Street ended higher on Tuesday during voting in midterm elections that will determine control of the US Congress, with investors betting on a political stalemate that could prevent major policy … Read more
Must prepare for scenario where ties with China sour Comments come day after Scholz trip to Beijing Tells German CEOs to diversify away from China BERLIN, Nov 5 (Reuters) – German Chancellor Olaf Scholz, who was heavily criticized for a trip to Beijing this week, said on Saturday his and Chinese President Xi Jinping’s joint … Read more
Nov 2 (Reuters) – CVS Health Corp (CVS.N), Walgreens Boots Alliance Inc (WBA.O) and Walmart Inc (WMT.N) have agreed to pay about $13.8 billion to resolve thousands of US state, local and tribal government lawsuits accusing the pharmacy chains of mishandling opioid painkillers. CVS said Wednesday it had agreed to pay about $5 billion over … Read more
JOHANNESBURG, Aug 4 (Reuters) – South Africa’s health regulator reported on Thursday a causal link between the death of an individual and Johnson & Johnson’s (J&J) (JNJ.N) COVID-19 vaccine, the first time such a direct link has been made in the country. The person presented with rare neurological disorder Guillain-Barre Syndrome soon after being given … Read more
WASHINGTON, July 30 (Reuters) – US President Joe Biden tested positive for COVID-19 again on Saturday in what the White House doctor described as a “rebound” case seen in a small percentage of patients who take the antiviral drug Paxlovid. Biden, 79, who emerged from COVID isolation on Wednesday after testing positive on July 21, … Read more
CHICAGO, July 29 (Reuters) – People at high risk of severe disease who have yet to get a second COVID-19 booster should not wait for next-generation, Omicron-targeted vaccines expected in the fall, five vaccine experts told Reuters. In many countries, including the United States, the BA.5 Omicron subvariant of the virus is surging, but current … Read more